Jana ChisholmSep 205 min readEyes on BioPharma HeadlinesThis month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait
Jana ChisholmFeb 83 min readEyes on BioPharma Portfolio StrategiesThis week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...
Robin BatemanMay 15, 20222 min readProduct Approvals, Delays & DisappointmentsThis was a busy week for Healthcare with 1Q22 Results. The PharmaTell Team had eyes on some of the US FDA decisions + Roche's SKYSCRAPER-01